Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Strong performer throughout 2025. Positive operational improvements...
— Mike Collins, Matt Clarke, Chase McIntosh, Carl Wiese
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Mama's Creations, Inc.
Mama’s Creations ($MAMA), holding a 4.27% allocation, manufactures and markets prepared, deli-counter protein-based culinary solutions for nationwide grocery retailers. Despite trimming the...
Since installing a new CEO in 2023, Mama's Creations has grown its tangible book value per share from $0.06 to $0.97 due to exceptional operational execution. Despite trading at...
Mama's Creations (MAMA – Doubted Champion) We have written about our investment in Mama's Creations almost ad nauseam.
More institutional theses from GROW Funds
Lead drug ZUNVEYL was FDA approved in July 2024 for Alzheimer's treatment. It is only...
Management is confident in a $16 billion pipeline, up from $3 billion two years ago. Orion won a...
Top performer serving defense, space, and energy markets. Sells critical propulsion...